varenicline has been researched along with Nicotine Addiction in 301 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 62 (20.60) | 29.6817 |
| 2010's | 209 (69.44) | 24.3611 |
| 2020's | 30 (9.97) | 2.80 |
| Authors | Studies |
|---|---|
| Babazono, A; Fujita, T; Jamal, A; Jiang, P; Li, Y | 1 |
| Kim, Y; Noh, HM; Paek, YJ; Park, MJ; Seo, YG; Yoon, JL | 1 |
| Evers-Casey, S; Leone, FT | 1 |
| Berk, M; Billeci, M; Carvalho, AF; Castle, DJ; de Bartolomeis, A; De Prisco, M; Fornaro, M; Iasevoli, F; Mondin, AM; Selby, P | 1 |
| Beloate, LN; Doolittle, J; Froeliger, B; Garcia-Keller, C; Kalivas, PW; Meyerink, ME; Nall, RW; Penaloza, T | 1 |
| Andreas, S; Batra, A; Gohlke, H; Kiefer, F; Klein, M; Kotz, D; Mons, U; Mühlig, S; Petersen, KU; Pötschke-Langer, M; Preuss, UW; Rustler, C; Rüther, T; Thomasius, R; Ulbricht, S | 1 |
| Bhuiyan, M; Chen, CT; Freifelder, R; Govind, AP; Green, WN; Holderman, N; Kao, CM; Kucharski, A; Mitchell, S; Mukherjee, J; Zammit, M; Zhang, HJ; Zhuang, X | 1 |
| Fitzpatrick, J; Good, CB; Lang, AE; Lee, T; McFarland, M; Patel, U | 1 |
| Chenoweth, MJ; Knight, J; Lerman, C; Tyndale, RF | 1 |
| Bastian, J; Bauer, AM; Fox, EN; Gollan, JK; Hitsman, B; Hole, A; Huffman, MD; Khan, SS; Leone, FT; Lubitz, SF; Mohr, DC; Niaura, R; Papandonatos, GD; Schnoll, RA; Veluz-Wilkins, AK; Wileyto, EP | 1 |
| Berlin, I; Lang, AE | 1 |
| Cabrera-César, E; de Granda-Orive, JI; De Higes-Martínez, E; García Rueda, M; Jiménez-Ruiz, CA; Pastor-Esplá, E; Rábade-Castedo, C; Ramos-Pinedo, Á; Riesco-Miranda, JA; Signes-Costa Miñana, J | 1 |
| Behm, FM; Botts, DR; Botts, TL; Rose, JE; Willette, PN | 1 |
| Baker, NL; Carpenter, MJ; Gray, KM; McClure, EA; Saladin, ME; Squeglia, LM; Tomko, RL | 1 |
| Flannery, JS; Laird, AR; Poudel, R; Riedel, MC; Ross, TJ; Salmeron, BJ; Stein, EA; Sutherland, MT | 1 |
| Xia, S; Zhao, S; Zhao, Y; Zhong, Z | 1 |
| Brestec, AL; Couturaud, F; Dansou, A; Dewitte, JD; Dion, A; Gagnadoux, F; Hayem-Vannimenus, C; Jouneau, S; Larhantec, G; Le Mao, R; Leroyer, C; Magnan, A; Paleiron, N; Proust, A; Roche, N; Sanchez, O; Tromeur, C | 1 |
| Lesage, E; Ross, TJ; Salmeron, BJ; Stein, EA; Sutherland, MT | 1 |
| Bassett, K; Carney, G; Dormuth, CR; Maclure, M; Taylor, S | 1 |
| Bardo, MT; Chandler, CM; Maggio, SE; Nixon, K; Peng, H | 1 |
| Moura, H | 1 |
| Huang, P; Jiaerken, Y; Li, K; Luo, X; Qian, W; Shen, Z; Wang, C; Wang, S; Yang, Y; Zeng, Q; Zhang, M; Zhou, C | 1 |
| Filipponi, A; Giordano, P; Giulietti, F; Iacoacci, C; Rosettani, G; Sarzani, R; Spannella, F | 1 |
| Adamcekova, Z; Kralikova, E; Kuhn, M; Noland, D; Pankova, A; Stepankova, L; Zvolska, K | 1 |
| Cruz-Lopes, L; Eakin, MN; Evers-Casey, S; Evins, AE; Farber, HJ; Fathi, J; Fennig, K; Folan, P; Fulone, I; Galiatsatos, P; Gogineni, H; Kantrow, S; Kathuria, H; Lamphere, T; Leone, FT; Murray, RL; Neptune, E; O'Brien, KK; Pacheco, MC; Pakhale, S; Pavalagantharajah, S; Prezant, D; Ross, S; Sachs, DPL; Toll, B; Upson, D; Xiao, D; Zhang, Y; Zhu, M | 1 |
| George, O; Smith, LC | 1 |
| Benipal, S; Bilimoria, K; Budhram, DR; Persaud, N; Wang, R; Woods, H | 1 |
| Davis, AM; Jain, A | 1 |
| Alamo, A; Campagna, D; Caponnetto, P; Cibella, F; Di Mauro, M; Franek, E; Frittitta, L; Krysiński, A; Leotta, C; Maglia, M; Mondati, E; Polosa, R; Russo, C | 1 |
| Abrishami, A; Andrawes, MSM; Chen, X; Chung, F; Islam, S; Korman, J; Riazi, S; Selby, P; Siddiqui, N; Wong, DT; Wong, J; You-Ten, E | 1 |
| Abe, M; Nakamura, M; Ohkura, M; Park, PW; Treadow, J; Yu, CR | 1 |
| Aronson, SE; Lesage, E; Ross, TJ; Salmeron, BJ; Stein, EA; Sutherland, MT | 1 |
| Almadana-Pacheco, V; Fouz-Rosón, N; Gómez-Bastero, AP; Montemayor-Rubio, T; Montserrat-García, S; Polo-Padillo, J; Romero-Muñoz, C | 1 |
| Arenella, PB; Calhoun, VD; Claus, ED; Hutchison, KE; Littlewood, RA; Mickey, J; Rachakonda, S; Wilcox, CE | 1 |
| Andreadou, I; Ikonomidis, I; Kourea, K; Lekakis, J; Liarakos, N; Marinou, M; Parissis, J; Pavlidis, G; Triantafyllidi, H; Tsougos, E; Vlastos, D | 1 |
| Baraona, LK; Daniels, JL; Lovelace, D; McDaniel, L | 1 |
| Asnaani, A; Foa, EB; Gariti, P; Imms, P; Rosenfield, D; Zandberg, LJ | 1 |
| Galanti, MR; Hansson, J; Janszky, I; Möller, J; Monárrez-Espino, J; Söderberg-Löfdal, K | 1 |
| Benowitz, NL; Cinciripini, P; George, TP; Hawk, LW; Lerman, C; Morales, M; Nollen, NL; Peng, AR; Schnoll, R; Tyndale, RF; Wileyto, EP | 1 |
| Bruguera, E; Cedillo, S; Rejas-Gutiérrez, J | 1 |
| Bidwell, LC; Bryan, AD; Hutchison, KE; Karoly, HC | 1 |
| Higuchi, S; Matsushita, S; Mimura, M; Suzuki, T; Uchida, H; Ueno, F; Yokoyama, A | 1 |
| Boffi, R; Colombo, F; Galvan, A; Noci, S; Pasetti, G; Pastorino, U; Pintarelli, G; Pozzi, P; Sala, F | 1 |
| Chan, CK; Chu, CW; Kao, CH | 1 |
| Le Foll, B; Lerman, C; Morales, M; Peng, AR; Schnoll, R; Tyndale, RF | 1 |
| Esterhuizen, TM; Irusen, EM; Koegelenberg, CFN; Noor, F | 1 |
| Chang, HC; Chang, PY; Lan, TH; Shiu, MN; Su, PY; Yuan, YT | 1 |
| Latimer, KM | 1 |
| Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Hurt, RT; Schroeder, DR | 1 |
| Geyer, MA; Phillips, AG; Robbins, TW | 1 |
| DeLannoy, I; Fletcher, PJ; Higgins, GA; Li, Z; MacMillan, C; Silenieks, LB | 1 |
| Kathuria, H; Leone, FT; Neptune, ER | 1 |
| Alkhlaif, Y; Bagdas, D; Carroll, FI; Damaj, MI; Ditre, JW; Jackson, A | 1 |
| Bastian, J; Carroll, A; Crawford, G; Flitter, A; Hitsman, B; Jao, NC; Kalhan, R; Leone, F; Schnoll, R; Weisbrot, J | 1 |
| Cinciripini, P; George, TP; Hawk, LW; Lerman, C; Peng, AR; Schnoll, R; Tyndale, RF | 1 |
| Bacchelli, E; Cainazzo, MM; Cameli, C; Cifiello, S; Collo, G; De Paola, M; Giucastro, G; Maestrini, E; Pini, LA; Zoli, M | 1 |
| Bozinoff, N; Le Foll, B | 1 |
| McMahon, LR; Moerke, MJ | 1 |
| McCarthy, DE; Versella, MV | 1 |
| Bondy, SJ; Chaiton, M; Cohen, JE; Diemert, LM; Ferrence, RG; Fung, MD; Zhang, BR | 1 |
| Bardo, MT; Bell, RL; Crooks, PA; Dwoskin, LP; Maggio, SE; Nixon, K; Prendergast, MA; Saunders, MA; Zheng, G | 1 |
| Cazzola, M; Hernández Zenteno, RJ; Lara, DF; Matera, MG; Pérez Padilla, JR; Pineda, JR; Sansores, RH; Trujillo, FF; Venegas, AR | 1 |
| Benowitz, NL; Chen, M; Cinciripini, PM; George, TP; Hawk, LW; Lerman, C; Li, L; Robinson, JD; Schnoll, RA; Tyndale, RF | 1 |
| Chandan, K; Mehrotra, R; Nethan, ST; Sinha, DN | 1 |
| Hauser, SR; Knight, CP; McBride, WJ; Pratt, LA; Rodd, ZA; Waeiss, RA | 1 |
| Cao, J; Jordan, CJ; Newman, AH; Xi, ZX | 1 |
| Baker, TB; Cook, JW; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Ashare, RL; Collman, RG; Frank, I; Gross, R; Hole, A; Leone, F; Metzger, D; Mounzer, K; Schnoll, R; Serrano, K; Thompson, M; Wileyto, EP | 1 |
| Brown, J; Jackson, SE; Kotz, D; West, R | 1 |
| Asnaani, A; Fitzgerald, HE; Foa, EB; Jerud, A; Kaczkurkin, AN | 1 |
| Fanshawe, TR; Hartmann-Boyce, J; Hong, B; Livingstone-Banks, J; Wheat, H | 1 |
| Alayoubi, H; Alkhlaif, Y; AlOmari, D; Bagdas, D; Carper, M; Damaj, MI; Diester, CM; Poklis, JL; Riley, J | 1 |
| Choi, J; Jo, MW; Paek, YJ; Seo, YG | 1 |
| Davies, NM; Itani, T; Jones, T; Martin, RM; Munafò, MR; Rai, D; Taylor, AE; Taylor, GMJ; Thomas, KH; Windmeijer, F | 1 |
| Milnerowicz, H; Sliwińska-Mossoń, M; Zieleń, I | 1 |
| Brady, KT; George, MS; Gray, KM; Hartwell, KJ; Lematty, T; McRae-Clark, AL | 1 |
| Abdul-Malak, Y; Ajagbe, TO; Batki, SL; Dimmock, JA; Meszaros, ZS; Wang, D | 1 |
| Tønnesen, P | 1 |
| Galaznik, A; Harnett, J; Kirchner, HL; Leader, JB; Liberman, JN; Lichtenfeld, MJ; Mastey, V; Zou, KH | 1 |
| Aubin, HJ; Berlin, I; Luquiens, A | 1 |
| Baker, MA; Brown, JS; Kornegay, C; Platt, R; Toh, S | 1 |
| Bölcskei, PL; Davis-Wagner, P; Grundnig, J; Pommer, P | 1 |
| Kurioka, N | 1 |
| Behm, FM; Rose, JE | 2 |
| Altet Gómez, N; Barrueco Ferrero, M; de Granda Orive, JI; Jiménez-Ruiz, CA; Lorza Blasco, JJ; Martinez Muñiz, MA; Ramos Pinedo, A; Riesco Miranda, JA; Signes-Costa Miñana, J; Solano Reina, S | 1 |
| Cowan, CM; Dezee, KJ; Wink, JS | 1 |
| Getsios, D; Ishak, KJ; Marton, JP; Revankar, N; Rublee, D; Ward, AJ; Willke, RJ; Xenakis, JG | 1 |
| Cahill, K; Hartmann-Boyce, J; Lancaster, T; Stead, LF | 2 |
| Goelz, P; Gupta, T; Jain, R; Jain, V; Jhanjee, S; Mittal, S; Schnoll, RA; Wileyto, EP | 1 |
| Anderson, BJ; Audet, D; Caviness, CM; Kurth, ME; Olson, J; Stein, MD | 1 |
| Eibl, C; Guendisch, D; Mineur, YS; Papke, RL; Peng, C; Picciotto, MR; Stokes, C; Tian, C; Tomassoli, I | 1 |
| Aubin, HJ; Le Houezec, J | 1 |
| Hughes, JR; Messig, MA; Russ, C | 1 |
| Dow, WH; Rungruanghiranya, S; White, JS | 1 |
| Carroll, FI; Fivel, PA; Kohut, SJ; Mello, NK | 1 |
| Achtyes, ED; Ayer, D; Cather, C; Evins, AE; Goff, DC; Hoeppner, SS; Pachas, GN; Pratt, SA; Schoenfeld, DA | 1 |
| Allen, SS; Croghan, IT; Ebbert, JO; Hatsukami, DK; Hays, JT; Hurt, RD; Schroeder, DR | 1 |
| Bertrand, D; Hurst, RS; Lee, TC; Rollema, H; Russ, C | 1 |
| Blendy, JA; DeDominicis, KE; Forcelli, PA; Hussmann, GP; Kellar, KJ; Klehm, J; Lindstrom, J; Richardson, JR; Sahibzada, N; Turner, JR; Wolfe, BB; Xiao, Y; Yasuda, RP | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP | 1 |
| Gupta, T; Jain, R; Majumder, P | 1 |
| Cieślewicz, A; Jabłecka, A; Korzeniowska, K | 1 |
| Hoope, C; Sedgwick, P | 1 |
| Fahrenwald, NL; Kerkvliet, JL | 1 |
| Austin, AJ; Duka, T; Jackson, A; Rusted, J | 1 |
| Ebbert, JO; Elrashidi, MY | 1 |
| Argue, DP; Cousin, MA; Ebbert, JO; Ekker, SC; Klee, EW; Urban, MD; Wiinamaki, AR | 1 |
| Arteaga, C; Nakamura, M; Ohkura, M; Oshima, A; Suwa, K | 1 |
| Davis, C; Galaznik, A; Joshi, AV; Patel, NC; Suehs, BT; Zou, KH | 1 |
| Arteaga, C; Brosky, G; Oh, P; Ranger, S; Raymond, V; Selby, P | 1 |
| Gonzales, D; Hajek, P; McRae, TD; Nackaerts, K; Pliamm, L; Treadow, J; Tseng, LJ | 1 |
| Kmeťová, A; Králíková, E; Zvolská, K | 1 |
| Abdool-Gaffar, MS; Bateman, ED; Bruning, A; Emanuel, S; Esterhuizen, TM; Irusen, EM; Koegelenberg, CF; Noor, F; O'Brien, JA; Smith, C; van Zyl-Smit, RN | 1 |
| Castillo-Fernández, E; Lara-Fernández, M; López-Quirantes, EM; López-Torrecillas, F; Nieto-Ruiz, A; Velasco-Ortuño, S | 1 |
| Erwin, BL; Slaton, RM | 1 |
| Baker, TB; Benowitz, NL; Bergen, AW; Conti, DV; Edlund, CK; Hall, SM; Javitz, HS; Kim, RB; Krasnow, R; Kwok, PY; McClure, JB; Michel, M; Nishita, D; Swan, GE; Tyndale, RF | 1 |
| Britton, J; Huang, Y; Lewis, S | 1 |
| Adams, S; Attwood, AS; McClernon, FJ; Munafò, MR; Williams, T | 1 |
| Baena, A; Masuet-Aumatell, C; Morchon, S; Ramon, JM | 1 |
| Broughton, AD; Hylick, EV; Smalls, TD; Woodard, TJ | 1 |
| Chan, S; Cheng, K; He, Y; Jiang, B; Lam, T; Liu, Q; Wu, L; Zhang, L; Zhou, C; Zuo, F | 1 |
| Brinson, AJ; Chengappa, KN; Forrest, PE; Gannon, JM; George, TP; Perkins, KA | 1 |
| Dutro, MP; Ebbert, JO; Hughes, JR; McRae, TD; Park, PW; Rennard, SI; Russ, C; Treadow, J; West, RJ; Yu, CR | 1 |
| Browning, KK; Diaz, P; Ferketich, AK; Koletar, SL; Reynolds, NR; Wewers, ME | 1 |
| Aveyard, P; Farley, A; Hollands, GJ; Lindson-Hawley, N; McDermott, MS; Vogt, F | 1 |
| Boffi, R; Marabelli, C; Munarini, E; Pozzi, P | 1 |
| Chang, Q; Hanania, T; Maillet, EL; Mash, DC | 1 |
| Cornwall, D; McRobbie, H; Przulj, D; Smith, KM | 1 |
| Chenoweth, MJ; Cinciripini, PM; George, TP; Hawk, LW; Lerman, C; Novalen, M; Schnoll, RA; Tyndale, RF | 1 |
| Furberg, RD; Krebs, P; Pham, H; Shelley, D; Sherman, SE; Tseng, TY; Wolfe, H; Wong, S | 1 |
| Abe, TO; Gaya, PV; Issa, JS; Krieger, JE; Pereira, AC; Santos, JR; Santos, PC; Tomaz, PR | 1 |
| Akerman, S; Bartels, S; Brunette, MF; Dzebisashvili, N; Ferron, JC; Xie, H | 1 |
| Andres, J; Berkling, K; Hering, T; Ruhr, HJ | 1 |
| Knudsen, HK; Roman, PM | 1 |
| Cummins, SE; Gamst, AC; Ikeda, T; Wong, S; Zhu, SH | 1 |
| Benowitz, NL; Prochaska, JJ | 1 |
| Baydur, H; Budak, R; Choussein, B; Doğanay, S; Ergör, G; Günay, T; Pekel, Ö | 1 |
| Backer, V; Porsbjerg, C; Westergaard, CG | 1 |
| Azuma, J; Fujio, Y; Hirohashi, K; Iguchi, T; Kobayashi, M; Maeda, M; Morimura, M; Norioka, N; Shimada, K; Shuto, T; Takemoto, Y; Yoshiyama, M | 1 |
| Cather, C; Evins, AE | 1 |
| Eden Evins, A; McNeill, A; Roberts, E; Robson, D | 1 |
| Clemens, KJ; Holmes, NM; Lay, BP | 1 |
| Au, DH; Collins, MP; Feemster, LC; Melzer, AC | 1 |
| Ahluwalia, JS; Benowitz, NL; Cox, LS; Ellerbeck, EF; Mayo, MS; Nollen, NL; Scheuermann, TS; Tyndale, RF; Yu, Q | 1 |
| Hurst, D | 1 |
| Ebbert, JO; Little, MA | 1 |
| Chan, SS; Cheng, KK; He, Y; Jiang, B; Lam, TH; Liu, QH; Wu, L; Zhang, L; Zhou, CX; Zuo, F | 1 |
| Bahadir, A; Bakan, ND; Iliaz, S; Ortakoylu, MG; Yazar, E; Yurt, S | 1 |
| Eisenberg, MJ; Filion, KB; Sterling, LH; Touma, L; Windle, SB | 1 |
| Aveyard, P; Hartmann-Boyce, J | 1 |
| Clemens, KJ; Holmes, NM; Macnamara, CL; Westbrook, RF | 1 |
| Prochaska, JJ | 1 |
| Abughosh, S; Chen, H; Essien, EJ; Johnson, ML; Peters, RJ; Wang, X; Yang, M | 1 |
| Ashare, RL; Cinciripini, PM; George, TP; Hawk, LW; Lerman, C; Rabin, RA; Schnoll, RA; Tyndale, RF | 1 |
| Blazekovic, S; Brubaker, TR; Hitsman, B; Hole, A; Kalhan, R; Langer, C; Leone, F; Patel, J; Price, S; Schnoll, R; Veluz-Wilkins, A; Wileyto, EP | 1 |
| Lawrence, D; Tonstad, S | 1 |
| Clyde, MJ; Els, C; Pipe, AL; Reid, RD; Tulloch, HE | 1 |
| Klein, JW | 1 |
| Uruma, R | 1 |
| Buhidma, Y; Jackson, A; Shoaib, M; Silk, S | 1 |
| Aitken, D; Mullen, KA; Pipe, AL; Pritchard, G; Reid, RD; Walker, K | 1 |
| Croghan, E; Kiparoglou, V; Robinson, H; van Woerden, HC; Walker, NJ; Yang, Y | 1 |
| Choi, DS; Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RT; Schroeder, DR | 1 |
| Cather, C; Cieslak, KM; Evins, AE; Hoeppner, BB; Hoeppner, SS; Maravic, MC; Pachas, GN; Schoenfeld, DA | 1 |
| Huang, P; Qian, W; Shen, Z; Wang, C; Yang, Y; Zhang, M | 1 |
| Arenella, PB; Calhoun, VD; Claus, ED; Goodreau, N; Hutchison, KE; Littlewood, RA; Mickey, J; Rachakonda, S; Wilcox, CE | 1 |
| Cather, C; Cieslak, KM; Evins, AE; Hoeppner, SS; Pachas, GN; Schoenfeld, D; Schuster, RM; Zhang, H | 1 |
| Ochoa, EL | 1 |
| Bélisle, P; Eisenberg, MJ; Filion, KB; Gervais, A; Joseph, L; Mottillo, S; O'Loughlin, J; Paradis, G; Pilote, L; Rinfret, S; Yavin, D | 1 |
| Nadeem, SS; Pirmoradi, P; Roshan, S | 1 |
| Ferguson, SG; Shiffman, S | 1 |
| Reus, VI; Smith, BJ | 1 |
| Gould, TJ; Lerman, C; Portugal, GS; Raybuck, JD | 1 |
| Benowitz, NL | 2 |
| Ebbert, JO; Hays, JT | 2 |
| Lyon, GJ | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Joyce, BM; Neugebauer, NM; Pivavarchyk, M; Zhang, Z; Zheng, G | 1 |
| Rose, JE | 1 |
| Galanti, LM | 1 |
| Schroeder, SA | 1 |
| Hering, T | 2 |
| Florek, E; Piekoszewski, W | 1 |
| Cantrell, MA; Geraets, D | 1 |
| Tavares, AR | 1 |
| Groman, E; Homaier, I; Lichtenschopf, A; Tschabitscher, P | 1 |
| Arora, G; Jain, M; Talwar, A | 1 |
| Ebbert, JO | 1 |
| Carpenter, LL; Philip, NS; Price, LH; Tyrka, AR; Whiteley, LB | 1 |
| Ferguson, SG; Gritz, ER; Henningfield, JE; Shiffman, S | 1 |
| Balvanz, TM; Magallon, HE; Mambourg, SE; Pham, RH; Purvis, TL | 1 |
| Dugan, SE; Garrison, GD | 1 |
| Diehl, A; Grosshans, M; Hermann, D; Mann, K; Mutschler, J | 1 |
| Heimlich, L; Steinberg, ML; Williams, JM | 1 |
| Chapin, DS; Freeman, J; Guanowsky, V; Hajós, M; Hoffmann, WE; Horner, WE; Johnson, DE; Kozak, R; Majchrzak, MJ; McLean, S; Rollema, H; Seymour, PA; Williams, KE | 1 |
| Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T | 1 |
| Herman, AI; Mooney, M; Sofuoglu, M; Waters, AJ | 1 |
| Maritz, GS | 1 |
| Clark, MM; Croghan, IT; Ebbert, JO; Hays, JT; Schroeder, DR; Sood, A | 1 |
| Batra, A; Friederich, HM | 1 |
| Hao, W; Tan, L; Tang, Q | 1 |
| Mead, AN; O'Connor, EC; Parker, D; Rollema, H | 1 |
| Burke, MV; Ebbert, JO; Hays, J; Wyatt, KD; Zirakzadeh, A | 1 |
| Jormanainen, V; Kotomäki, T; Linden, K; Linna, M; Sintonen, H; Wilson, K | 1 |
| Corelli, RL; Hudmon, KS; Prokhorov, AV | 1 |
| Keating, GM; Lyseng-Williamson, KA | 2 |
| Bartlett, SE; Chatterjee, S | 1 |
| Drach, L; Fox, V; Holbert, T; Maher, J; Saddler, LC; Schubert, S | 1 |
| Biala, G; Budzynska, B; Staniak, N | 1 |
| Bertrand, D; Bertrand, S; Coe, JW; Cremers, T; de Vries, M; Hurst, RS; Mather, RJ; O'Neill, BT; Rollema, H; Shrikhande, A; Tingley, FD; Tseng, E; Wang, EQ; Ward, KM; Williams, KE | 1 |
| Hayashi, K; Hori, H; Hoshuyama, T; Ikenouchi-Sugita, A; Katsuki, A; Nakamura, J; Umene-Nakano, W; Yoshii, C; Yoshimura, R | 1 |
| Beck, HN; Biazzo, LL; Campbell, SL; Froshaug, DB; Harwell, TS; Haugland, C; Helgerson, SD | 1 |
| Hays, JT; Lawrence, D; Lee, TC; Leischow, SJ | 1 |
| Hizue, M; Ishibashi, T; Nomura, S | 1 |
| Bhat, A; Crain, D | 1 |
| Herman, AI; Sofuoglu, M | 1 |
| Ruff, P | 1 |
| Zeller, A | 1 |
| Garelik, DA | 1 |
| Ayesta Ayesta, FJ; Minué Lorenzo, C; Olano Espinosa, E | 1 |
| Baker, CL; Bushmakin, AG; Cappelleri, JC; Croghan, IT; Hays, JT | 1 |
| Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Schroeder, DR | 1 |
| Mineur, YS; Picciotto, MR | 1 |
| Anderson, KD; Campbell, AR | 1 |
| Cesario, A; Galetta, D; Granone, P; Greenberg, DS; Margaritora, S; Russo, P; Rutella, S; Spaggiari, L; Veronesi, G | 1 |
| Booij, J; Crunelle, CL; de Bruin, K; Miller, ML; Schulz, S; van den Brink, W | 1 |
| Fagerström, K; Gilljam, H; Messig, M; Metcalfe, M; Tonstad, S | 1 |
| Lancaster, T; Stead, L | 1 |
| Balmford, J; Borland, R; Cummings, KM; Hammond, D | 1 |
| Childress, AR; Cruz, J; Detre, JA; Franklin, T; Goldman, M; Hazan, R; Li, Y; O'Brien, CP; Suh, JJ; Wang, Z | 1 |
| Weinsier, ST | 1 |
| Boudrez, H; Gratziou, C; Messig, M; Metcalfe, M | 1 |
| Chatterjee, A; Garza, D; Murphy, M; Riordan, HJ; Tseng, LJ | 1 |
| Caro, JJ; Davies, S; Ishak, KJ; Kinter, ET; Marton, JP; Ward, AJ; Willke, RJ; Xenakis, JG | 1 |
| Ahluwalia, JS; Cox, LS; Ellerbeck, EF; Nazir, N; Nollen, NL; Owen, A; Pankey, S; Thompson, N | 1 |
| Croghan, IT; Ebbert, JO; Hays, JT; Schroeder, DR; Severson, HH | 1 |
| Aubin, HJ; Karila, L; Reynaud, M | 1 |
| O'Malley, SS | 1 |
| Beebe, LA; Choi, WS; Cully, L; Daley, CM; Faseru, B; Greiner, AK; Kaur, B; Shireman, TI; Talawyma, M; Yeh, HW | 1 |
| Foulds, J; Gandhi, KK; Steinberg, MB; Steinberg, ML; Ulpe, R; Williams, JM | 1 |
| Bigman, C; Cappella, J; Leone, F; Lerman, C; Patterson, F; Pinto, A; Schnoll, RA; Wileyto, EP | 1 |
| Jones, DL; Rankin, KV | 1 |
| Carson, JL; Greenhaus, S; Randall, J; Richardson, DL; Schmelzer, AC; Steinberg, MB | 1 |
| Barnes, C; Chakraborty-Chatterjee, M; Gamaleddin, I; Goldberg, SR; Khaled, M; Le Foll, B; Lev-Ran, S; Pushparaj, A; Yan, Y | 1 |
| Caggiula, AR; Donny, EC; Levin, ME; Palmatier, MI; Sved, AF; Weaver, MT | 1 |
| Hayashi, K; Hori, H; Ikenouchi-Sugita, A; Katsuki, A; Nakamura, J; Umene-Nakano, W; Yoshii, C; Yoshimura, R | 1 |
| Benowitz, NL; Bierut, LJ; Conti, DV; Kaprio, J; King, DP; Lerman, C; Paciga, S; Park, PW; Pickering, E | 1 |
| Browning, KK; Ferketich, AK; Hall, N; King, M; Otterson, GA; Wewers, ME | 1 |
| Fidler, J; Kotz, D; West, R | 1 |
| Ashare, RL; Cummings, KM; Gass, JC; Hawk, LW; Lohnes, SF; Mahoney, MC; Rhodes, JD; Schlienz, NJ; Tiffany, ST | 1 |
| Cicero Guerrero, A; Cristobal Fernández, M; Jiménez Ruiz, CA; Lopez Gonzalez, G; Mayayo Ulibarri, M; Ramos Pinedo, A | 1 |
| Ahluwalia, JS; Benowitz, NL; Berg, CJ; Buchanan, TS; Choi, WS; Cox, LS; Jacob, P; Nazir, N; Nollen, NL; Yturralde, O; Yu, L | 1 |
| Anderson, BJ; Audet, DA; de Dios, MA; Stanton, C; Stein, M | 1 |
| Fagerström, K; Foulds, J; Russ, C; Yu, CR; Yunis, C | 1 |
| Christalla, P; Dewenter, M; El-Armouche, A | 1 |
| Hilton, JF; Prochaska, JJ | 1 |
| Athanasakis, K; Igoumenidis, M; Karampli, E; Kyriopoulos, J; Sykara, G; Vitsou, E | 1 |
| Abrishami, A; Chapman, KR; Chung, F; Friedman, Z; Selby, P; Wong, J; Yang, Y; Zaki, A | 1 |
| Andreas, S; Chenot, JF; Diebold, R; Mann, K; Peachey, S | 1 |
| Jao, NC; Karelitz, JL; Perkins, KA | 1 |
| Argo, T; Cantrell, M; Haak, L; Janney, L | 1 |
| Rigotti, NA | 1 |
| Anthony, JC; Behm, FM; Eaton, WW; Fisher, C; Ialongo, N; Musci, R; Rose, JE; Storr, CL; Uhl, GR; Walther, D | 1 |
| Dautzenberg, B | 1 |
| Camarelles Guillem, F; Clemente Jiménez, L; Dalmau González-Gallarza, R; Díaz-Maroto Muñoz, JL; Lozano Polo, A; Pinet Ogué, MC | 1 |
| Bernabé Barrios, MJ; Rodríguez Hermosa, JL; Santamaría Rodríguez, B; Zamarro García, C | 1 |
| Baker, CL; Bushmakin, AG; Cappelleri, JC; Gilbert, DG; Merikle, E; Olufade, AO | 1 |
| Camarelles Guillem, F | 1 |
| Aveyard, P | 1 |
| Foulds, J | 1 |
| Jones, C; Kirkpatrick, P; Niaura, R | 1 |
| Mogg, A; Peacey, E; Pullar, IA; Smith, JW; Szekeres, P; Tafi, E; Tricklebank, M | 1 |
| Siu, EC; Tyndale, RF | 1 |
| Tonstad, S | 1 |
| Coe, JW; Faessel, H; Obach, RS; Reeves, K; Reus, VI; Rollema, H; Watsky, E | 1 |
| Frishman, WH | 1 |
| Evans, SE; Leischow, S; Nides, M; Sarna, L | 1 |
| Bornstein, MM; Klingler, K; Ramseier, CA; Saxer, UP; Walter, C | 1 |
| Crane, R | 1 |
| Chambers, LK; Coe, JW; Hurst, RS; Rollema, H; Stahl, SM; Williams, KE | 1 |
| Anthenelli, RM | 1 |
| O'Brien, CP | 3 |
| Lerman, C; Patterson, F; Schnoll, RA | 1 |
| George, TP; Le Foll, B | 1 |
| Milbrandt, A; Ratcliffe, M; Smith, R; Spirling, LI; Stapleton, JA; Sutherland, G; Watson, L | 1 |
| Andrews, JO; Bennett, SM; Heath, JH | 1 |
| Baker, CL; Bushmakin, AG; Cappelleri, JC; West, R | 1 |
78 review(s) available for varenicline and Nicotine Addiction
| Article | Year |
|---|---|
Tobacco Use Disorder.
Topics: Behavior, Addictive; Bupropion; Combined Modality Therapy; Counseling; Drug Therapy; Electronic Nicotine Delivery Systems; Humans; Morbidity; Neurobiology; Nicotine; Nicotinic Agonists; Phenotype; Prevalence; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline | 2022 |
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis.
Topics: Humans; Male; Mental Disorders; Prevalence; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2022 |
Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023.
Topics: Adolescent; Alcoholism; Bupropion; Female; Humans; Nicotinic Agonists; Pregnancy; Pulmonary Medicine; Smoking Cessation; Thoracic Surgery; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2023 |
Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials.
Topics: Adult; Bupropion; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Varenicline | 2019 |
Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.
Topics: Alkaloids; Azocines; Bupropion; Clinical Decision-Making; Electronic Nicotine Delivery Systems; Humans; Quinolizines; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2020 |
Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.
Topics: Animals; Antidepressive Agents; Bupropion; Disease Models, Animal; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Receptors, Nicotinic; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2020 |
Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women.
Topics: Bupropion; Female; Fetus; Humans; Lactation; Nicotiana; Nicotine; Pregnancy; Pregnant Women; Smoking; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2017 |
Lung Cancer: Smoking Cessation.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Humans; Mass Screening; Nicotinic Agonists; Psychotherapy, Group; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2018 |
Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Depressive Disorder; Drug Discovery; Humans; Ketamine; Mental Disorders; Models, Animal; Nicotinic Agonists; Tobacco Use Disorder; Varenicline | 2018 |
Treatment of tobacco dependence: current state of the art.
Topics: Bupropion; Directive Counseling; Early Detection of Cancer; Humans; Lung Neoplasms; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2018 |
Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment.
Topics: Bupropion; Combined Modality Therapy; Humans; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline | 2018 |
Smokeless tobacco cessation interventions: A systematic review.
Topics: Behavior Therapy; Hotlines; Humans; Nicotinic Agonists; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2018 |
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
Topics: Analgesics, Opioid; Buprenorphine; Central Nervous System Stimulants; Cocaine-Related Disorders; Dextroamphetamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Development; Humans; Methadone; Methylphenidate; Modafinil; Nicotinic Agonists; Opiate Substitution Treatment; Opioid-Related Disorders; Oxalates; Piperazines; Receptors, Opioid, mu; Tobacco Use Disorder; Tropanes; Varenicline | 2019 |
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
Topics: Behavior Therapy; Bupropion; Combined Modality Therapy; Female; Humans; Nicotinic Agonists; Nortriptyline; Pregnancy; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2019 |
[Drugs used to treat nicotine addiction].
Topics: Adult; Age Distribution; Alkaloids; Azocines; Benzazepines; Bupropion; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Poland; Quinolizines; Quinoxalines; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline; Young Adult | 2012 |
Smoking cessation and COPD.
Topics: Benzazepines; Bupropion; Counseling; Humans; Nicotine; Nicotinic Agonists; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.
Topics: Adolescent; Benzazepines; Bupropion; Counseling; Drug Design; Female; Humans; Molecular Sequence Data; Pregnancy; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2014 |
[Current approaches to smoking cessation].
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Cooperative Behavior; Cross-Sectional Studies; Dopamine Uptake Inhibitors; Female; Germany; Health Priorities; Health Surveys; Humans; Interdisciplinary Communication; Male; Middle Aged; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2013 |
[On oral medications, especially varenicline].
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.
Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Harm Reduction; Humans; Nicotinic Agonists; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Nicotinic receptor antagonists as treatments for nicotine abuse.
Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Humans; Nicotinic Antagonists; Quinoxalines; Receptors, Nicotinic; Smoking; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Pharmacological intervention of nicotine dependence.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Emerging drugs for the treatment of tobacco dependence: 2014 update.
Topics: Atomoxetine Hydrochloride; Benzazepines; Bupropion; Clinical Trials as Topic; Clonidine; Humans; Mecamylamine; Nicotine; Nortriptyline; Propylamines; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2014 |
Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Counseling; Female; Humans; Male; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; School Health Services; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Varenicline in the treatment of alcohol use disorders.
Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Disorder; Varenicline | 2014 |
Interventions to increase adherence to medications for tobacco dependence.
Topics: Benzazepines; Bupropion; Drug Therapy, Combination; Humans; Medication Adherence; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2015 |
The Past, Present, and Future of Nicotine Addiction Therapy.
Topics: Alkaloids; Azocines; Bupropion; Directive Counseling; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Health Policy; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Social Media; Text Messaging; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Effective Cessation Strategies for Smokers with Schizophrenia.
Topics: Antipsychotic Agents; Behavior Therapy; Bupropion; Humans; Schizophrenia; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2015 |
Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
Topics: Bupropion; Humans; Mental Disorders; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2016 |
The safety of treatments for tobacco use disorder.
Topics: Bupropion; Delayed-Action Preparations; Humans; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2016 |
Pharmacotherapy for Substance Use Disorders.
Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
[Smoking cessation for COPD].
Topics: Health Education; Humans; Pulmonary Disease, Chronic Obstructive; Risk; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Managing smoking cessation.
Topics: Aftercare; Behavior Therapy; Bupropion; Canada; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
The relevance and treatment of cue-induced cravings in tobacco dependence.
Topics: Adaptation, Psychological; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cues; Extinction, Psychological; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Drugs for tobacco dependence.
Topics: Adrenergic alpha-Agonists; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines.
Topics: Benzazepines; Combined Modality Therapy; Complementary Therapies; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Psychotherapy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.
Topics: Animals; Behavior, Addictive; Benzazepines; Bupropion; Ganglionic Stimulants; Humans; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Quinoxalines; Smoking; Tobacco Use Disorder; Varenicline | 2009 |
Varenicline for tobacco dependence.
Topics: Benzazepines; Brain; Coronary Artery Disease; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
New findings on nicotine addiction and treatment.
Topics: Animals; Benzazepines; Bupropion; Humans; Mecamylamine; Motivation; Nicotine; Nicotinic Antagonists; Quinoxalines; Reward; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
Tobacco smoking cessation management: integrating varenicline in current practice.
Topics: Behavior Therapy; Benzazepines; Bupropion; Drug Partial Agonism; Health Policy; Humans; Nicotinic Agonists; Public Policy; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
[Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Emerging drugs for the treatment of tobacco dependence.
Topics: Animals; Benzazepines; Clinical Trials as Topic; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.
Topics: Animals; Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Varenicline: a first-line treatment option for smoking cessation.
Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Drug Costs; Drug Interactions; Drug Partial Agonism; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Tobacco use among individuals with intellectual or developmental disabilities: a brief review.
Topics: Adult; Benzazepines; Bupropion; Counseling; Cross-Sectional Studies; Disabled Persons; Health Policy; Humans; Nicotine; Persons with Mental Disabilities; Quinoxalines; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder; United States; Varenicline | 2009 |
Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring.
Topics: Animals; Antioxidants; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Maternal-Fetal Exchange; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Respiratory System; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2009 |
Nicotine dependence and smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.
Topics: Benzazepines; Cardiovascular Diseases; Drug Labeling; Humans; Mental Disorders; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Current approaches to pharmacotherapy for smoking cessation.
Topics: Adolescent; Adult; Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline | 2010 |
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Delayed-Action Preparations; Health Care Costs; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Prevalence; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.
Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Benzazepines; Brain; Humans; Mecamylamine; Neurons; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline | 2010 |
[Pharmacological profile and clinical findings on varenicline tartrate (Champix tablets)].
Topics: Animals; Benzazepines; Clinical Trials, Phase III as Topic; Corpus Striatum; Dopamine; Humans; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Comparison of available treatments for tobacco addiction.
Topics: Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nortriptyline; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2010 |
Pharmacoeconomic spotlight on varenicline as an aid to smoking cessation.
Topics: Benzazepines; Cost-Benefit Analysis; Health Care Costs; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
[Pharmacotherapies for nicotine dependence: review of scientific evidence. Spanish Society of Smoking Specialists: recommendations about election and individualization].
Topics: Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Tobacco Use Disorder; Varenicline | 2011 |
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis.
Topics: Acetylcholine; Animals; Antidepressive Agents; Benzazepines; Depressive Disorder; Drug Partial Agonism; Humans; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Receptors, Cholinergic; Self Medication; Signal Transduction; Suicidal Ideation; Tobacco Use Disorder; Varenicline | 2010 |
Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment.
Topics: Benzazepines; Bupropion; Genetic Variation; Humans; Nicotine; Protein Subunits; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Pharmacotherapy for smoking cessation: present and future.
Topics: Adolescent; Animals; Benzazepines; Bupropion; Delayed-Action Preparations; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2011 |
Varenicline for tobacco dependence: panacea or plight?
Topics: Animals; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2011 |
[Effectiveness and safety of varenicline for smoking cessation].
Topics: Benzazepines; Clinical Trials as Topic; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2012 |
Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis.
Topics: Adult; Benzazepines; Cardiovascular Diseases; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Tobacco Use Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
[Smoking in COPD].
Topics: Benzazepines; Bupropion; Clonidine; Comorbidity; Disease Progression; Europe; Humans; Motivation; Nicotinic Agonists; Nortriptyline; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2011 |
The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
Topics: Benzazepines; Brain; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2006 |
Non-nicotinic therapies for smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drugs, Investigational; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Varenicline for smoking cessation.
Topics: Benzazepines; Humans; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2007 |
Varenicline: new treatment with efficacy in smoking cessation.
Topics: Benzazepines; Clinical Trials as Topic; Drug Interactions; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2007 |
Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions.
Topics: Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Directive Counseling; Hospitalization; Humans; Internet; Physician's Role; Practice Patterns, Physicians'; Quinoxalines; Receptors, Nicotinic; Risk Reduction Behavior; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician.
Topics: Age Factors; Benzazepines; Bupropion; Complementary Therapies; Dopamine Uptake Inhibitors; Dosage Forms; Humans; Nicotine; Nicotinic Agonists; Physician's Role; Primary Health Care; Quinoxalines; Referral and Consultation; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.
Topics: Animals; Benzazepines; Drug Design; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2007 |
Treating tobacco dependence in women.
Topics: Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Lung Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline; Women's Health | 2007 |
Treatment of tobacco dependence: integrating recent progress into practice.
Topics: Behavior Therapy; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Health Behavior; Health Policy; Humans; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Quinoxalines; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Breaking the ties of nicotine dependence.
Topics: Algorithms; Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Costs; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Acceptance of Health Care; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Prevalence; Primary Health Care; Quinoxalines; Risk Factors; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Follow-Up Studies; Humans; Middle Aged; Motivation; Multicenter Studies as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American; Bupropion; Cotinine; Cues; Cytochrome P-450 CYP2A6; Drug Tolerance; Genetic Predisposition to Disease; Harm Reduction; Humans; Menthol; Mixed Function Oxygenases; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Reinforcement, Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline; White People | 2008 |
75 trial(s) available for varenicline and Nicotine Addiction
| Article | Year |
|---|---|
Influence of CYP2A6 Genetic Variation, Nicotine Dependence Severity, and Treatment on Smoking Cessation Success.
Topics: Adult; Cytochrome P-450 CYP2A6; Female; Genetic Variation; Humans; Male; Nicotine; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2023 |
Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial.
Topics: Adult; Benzazepines; Depressive Disorder, Major; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2023 |
Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial.
Topics: Adolescent; Counseling; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Retrospective Studies; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2019 |
Effect of Early Initiation of Varenicline on Smoking Cessation in COPD Patients Admitted for Exacerbation: The Save Randomized Clinical Trial.
Topics: Aged; Counseling; Disease Progression; Early Medical Intervention; Female; Hospitalization; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2020 |
A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Male; Middle Aged; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2021 |
A Perioperative Smoking Cessation Intervention With Varenicline, Counseling, and Fax Referral to a Telephone Quitline Versus a Brief Intervention: A Randomized Controlled Trial.
Topics: Aged; Comparative Effectiveness Research; Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Nicotinic Agonists; Patient Education as Topic; Perioperative Period; Prevalence; Prospective Studies; Referral and Consultation; Risk; Smoking; Smoking Cessation; Telefacsimile; Telephone; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2017 |
Efficacy of Varenicline for Cigarette Reduction Before Quitting in Japanese Smokers: A Subpopulation Analysis of the Reduce to Quit Trial.
Topics: Adult; Asian People; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Odds Ratio; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2017 |
Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.
Topics: Adult; Cerebral Cortex; Cross-Over Studies; Double-Blind Method; Executive Function; Female; Humans; Impulsive Behavior; Limbic System; Male; Motivation; Nicotine; Receptors, Nicotinic; Reversal Learning; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2017 |
Effect of 0.5 mg versus 1 mg varenicline for smoking cessation: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Smoking Cessation; Spain; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2017 |
Functional network connectivity predicts treatment outcome during treatment of nicotine use disorder.
Topics: Adult; Brain; Corpus Striatum; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Nicotinic Agonists; Smoking; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2017 |
Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program.
Topics: Adult; Aged; Breath Tests; Carbon Monoxide; Endothelial Cells; Female; Glycocalyx; Greece; Humans; Male; Malondialdehyde; Middle Aged; Nicotinic Agonists; Oxidative Stress; Protein Carbonylation; Pulse Wave Analysis; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline; Vascular Stiffness | 2017 |
Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: A randomized controlled trial.
Topics: Adult; Combined Modality Therapy; Counseling; Female; Humans; Implosive Therapy; Male; Middle Aged; Nicotinic Agonists; Outcome Assessment, Health Care; Smoking Cessation; Stress Disorders, Post-Traumatic; Tobacco Use Disorder; Varenicline | 2017 |
Predictors of treatment success in smoking cessation with varenicline combined with nicotine replacement therapy v. varenicline alone.
Topics: Adult; Age Factors; Breath Tests; Carbon Monoxide; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Predictive Value of Tests; Smoking; Smoking Cessation; South Africa; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2017 |
Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.
Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Smokers; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2018 |
Predictors of Varenicline Adherence Among Cancer Patients Treated for Tobacco Dependence and its Association With Smoking Cessation.
Topics: Adult; Female; Humans; Male; Medication Adherence; Middle Aged; Neoplasms; Self Report; Smoking Cessation; Smoking Cessation Agents; Tobacco Smoking; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2019 |
Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes.
Topics: Adult; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Pharmacogenetics; Predictive Value of Tests; Self Report; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2018 |
Quitting Failure and Success With and Without Using Medication: Latent Classes of Abstinence and Adherence to Nicotine Monotherapy, Combination Therapy, and Varenicline.
Topics: Adult; Combined Modality Therapy; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2019 |
Evaluating the temporal relationships between withdrawal symptoms and smoking relapse.
Topics: Adult; Combined Modality Therapy; Counseling; Craving; Female; Humans; Male; Middle Aged; Recurrence; Reinforcement, Psychology; Smoking; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2019 |
Anxiety Sensitivity and Distress Tolerance in Smokers: Relations With Tobacco Dependence, Withdrawal, and Quitting Success†.
Topics: Adolescent; Adult; Anxiety Disorders; Child; Ecological Momentary Assessment; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smokers; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Varenicline; Young Adult | 2020 |
Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV.
Topics: Adult; Aged; Double-Blind Method; Female; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Smokers; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2019 |
Resisting the urge to smoke and craving during a smoking quit attempt on varenicline: results from a pilot fMRI study.
Topics: Adult; Arousal; Behavior, Addictive; Benzazepines; Cues; Female; Frontal Lobe; Functional Neuroimaging; Humans; Learning; Male; Memory; Neural Pathways; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2013 |
Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Adapting smoking cessation treatment according to initial response to precessation nicotine patch.
Topics: Adult; Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Synergism; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Premedication; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Internet versus in-person counseling for patients taking varenicline for smoking cessation.
Topics: Adult; Benzazepines; Counseling; Female; Humans; Internet; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline | 2013 |
A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India.
Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; India; Male; Placebo Effect; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline; Young Adult | 2014 |
Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.
Topics: Adult; Benzazepines; Carbon Monoxide; Female; Follow-Up Studies; Guideline Adherence; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Patient Compliance; Quinoxalines; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder; Varenicline | 2013 |
Association of deferring a quit attempt with smoking cessation success: a secondary analysis.
Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Commitment contracts and team incentives: a randomized controlled trial for smoking cessation in Thailand.
Topics: Adult; Aged; Benzazepines; Contracts; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Quinoxalines; Rural Population; Smoking Cessation; Thailand; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
Topics: Adult; Aged; Benzazepines; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Schizophrenia; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2014 |
Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Effect of varenicline on aspects of inhibitory control in smokers.
Topics: Adult; Benzazepines; Double-Blind Method; Executive Function; Female; Humans; Inhibition, Psychological; Male; Neuropsychological Tests; Nicotinic Agonists; Prospective Studies; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION).
Topics: Benzazepines; Bupropion; Canada; Female; Health Services Accessibility; Humans; Insurance, Health; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial.
Topics: Adult; Aged; Australia; Benzazepines; Canada; Chi-Square Distribution; Counseling; Double-Blind Method; Europe; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Recurrence; Retreatment; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome; United States; Varenicline; Young Adult | 2014 |
Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
Topics: Adult; Aged; Benzazepines; Bupropion; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; Varenicline | 2014 |
Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
Topics: Adult; Benzazepines; Breath Tests; Carbon Monoxide; Cholinergic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Organic cation transporter variation and response to smoking cessation therapies.
Topics: Adult; Benzazepines; Female; Genetic Variation; Humans; Male; Middle Aged; Organic Cation Transport Proteins; Organic Cation Transporter 2; Polymorphism, Single Nucleotide; Prospective Studies; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2014 |
Effects of varenicline and cognitive bias modification on neural response to smoking-related cues: study protocol for a randomized controlled study.
Topics: Affect; Benzazepines; Clinical Protocols; Cognitive Behavioral Therapy; Combined Modality Therapy; Craving; Cues; England; Humans; Magnetic Resonance Imaging; Nicotinic Agonists; Quinoxalines; Research Design; Smoking; Smoking Cessation; Smoking Prevention; Stroop Test; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation.
Topics: Administration, Cutaneous; Adolescent; Adult; Benzazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
An association between the use of hypnotics and quit status in the treatment of nicotine dependence with varenicline in bipolar disorder.
Topics: Bipolar Disorder; Double-Blind Method; Humans; Hypnotics and Sedatives; Sleep Wake Disorders; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2015 |
Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial.
Topics: Adult; Aged; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2015 |
Complementing the Standard Multicomponent Treatment for Smokers With Denicotinized Cigarettes: A Randomized Trial.
Topics: Adult; Behavior Therapy; Female; Humans; Male; Middle Aged; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Prospective Studies; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.
Topics: Bupropion; Combined Modality Therapy; Counseling; Cytochrome P-450 CYP2B6; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Protein Serine-Threonine Kinases; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2015 |
Expanding Cessation Pharmacotherapy Via Videoconference Educational Outreach to Prescribers.
Topics: Adult; Community Mental Health Services; Female; Humans; Male; Medicaid; Mental Disorders; Middle Aged; Prescriptions; Psychiatry; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline; Videoconferencing | 2015 |
[Real-Life Evaluation of the Compact Program for Smoking Cessation].
Topics: Adolescent; Adult; Aged; Behavior Therapy; Combined Modality Therapy; Female; Germany; Health Promotion; Humans; Longitudinal Studies; Male; Middle Aged; Prevalence; Program Evaluation; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2015 |
The effect of Varenicline on smoking cessation in a group of young asthma patients.
Topics: Adolescent; Adult; Asthma; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Medication Adherence; Quality of Life; Severity of Illness Index; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Vital Capacity; Young Adult | 2015 |
A clinical trial to examine disparities in quitting between African-American and White adult smokers: Design, accrual, and baseline characteristics.
Topics: Adult; Black or African American; Cohort Studies; Counseling; Female; Health Status Disparities; Humans; Male; Nicotinic Agonists; Prospective Studies; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; White People | 2016 |
Effectiveness of varenicline and counselling for smoking cessation in an observational cohort study in China.
Topics: Adult; Ambulatory Care Facilities; Beijing; Counseling; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Physicians; Prospective Studies; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2016 |
Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Marijuana Smoking; Middle Aged; Prospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2016 |
Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Topics: Directive Counseling; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2016 |
Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.
Topics: Adult; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Obesity; Overweight; Pilot Projects; Tobacco Use Disorder; Varenicline; Weight Gain; Young Adult | 2017 |
Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder.
Topics: Adult; Bipolar Disorder; Cognitive Behavioral Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Probability; Schizophrenia; Smokers; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2017 |
Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.
Topics: Adult; Affect; Benzazepines; Blood Pressure; Cognition Disorders; Cotinine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Quinoxalines; Severity of Illness Index; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study.
Topics: Adult; Appetite Depressants; Benzazepines; Cyclobutanes; Drug Therapy, Combination; Female; Humans; Nicotinic Agonists; Patient Dropouts; Pilot Projects; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline; Weight Gain; Young Adult | 2009 |
Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Female; Humans; Male; Medication Adherence; Middle Aged; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2010 |
Changes in health-related quality of life with smoking cessation treatment.
Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Health Status; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quality of Life; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.
Topics: Adult; Aged; Aged, 80 and over; Alcoholism; Behavior Therapy; Benzazepines; Comorbidity; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Temperance; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2011 |
Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial.
Topics: Adult; Benzazepines; Cotinine; Double-Blind Method; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Recurrence; Saliva; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Treatment Outcome; Varenicline | 2010 |
Effects of varenicline on smoking cue–triggered neural and craving responses.
Topics: Adult; Basal Ganglia; Benzazepines; Conditioning, Psychological; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Male; Motivation; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2011 |
Effectiveness of varenicline as an aid to smoking cessation: results of an inter-European observational study.
Topics: Adult; Aged; Belgium; Benzazepines; Europe; Female; Greece; Humans; Hungary; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Observation; Quinoxalines; Slovenia; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2011 |
A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
Topics: Adolescent; Adult; Aged; Aggression; Anxiety; Benzazepines; Depression; Double-Blind Method; Female; Humans; Irritable Mood; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Psychiatric Status Rating Scales; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
A pilot clinical trial of varenicline for smoking cessation in black smokers.
Topics: Adult; Behavior Therapy; Benzazepines; Black or African American; Combined Modality Therapy; Counseling; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline | 2011 |
A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Humans; Male; Midwestern United States; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline; Young Adult | 2011 |
Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial.
Topics: Benzazepines; Bupropion; Counseling; Cultural Characteristics; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Indians, North American; Kansas; Nicotinic Agonists; Oklahoma; Patient Education as Topic; Quinoxalines; Research Design; Self-Help Groups; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial.
Topics: Adult; Benzazepines; Female; Health Behavior; Humans; Male; Middle Aged; Minority Groups; Nicotinic Agonists; Patient Selection; Quinoxalines; Racial Groups; Research Design; Smoking; Smoking Cessation; Telephone; Tobacco Use Disorder; Varenicline | 2011 |
Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline.
Topics: Adult; Aged; Behavior Therapy; Benzazepines; Counseling; Double-Blind Method; Feasibility Studies; Female; Hospitalization; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2011 |
Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.
Topics: Adult; Aged; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pharmacogenetics; Quinoxalines; Research Design; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
A pilot test of a combined tobacco dependence treatment and lung cancer screening program.
Topics: Benzazepines; Early Detection of Cancer; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tomography, X-Ray Computed; Varenicline | 2012 |
The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial.
Topics: Behavior, Addictive; Benzazepines; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Quinoxalines; Sex Characteristics; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Varenicline | 2012 |
Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers.
Topics: Adult; Behavior Therapy; Benzazepines; Combined Modality Therapy; Double-Blind Method; Female; Follow-Up Studies; Hispanic or Latino; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Recurrence; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data.
Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; Linear Models; Male; Middle Aged; Nicotinic Agonists; Placebo Effect; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Disorder; Varenicline | 2012 |
A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Cotinine; Counseling; Double-Blind Method; Female; Health Promotion; Humans; Logistic Models; Male; Middle Aged; Perioperative Care; Postoperative Complications; Prospective Studies; Quinoxalines; Recurrence; Sample Size; Smoking; Smoking Cessation; Telephone; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2012 |
Effectiveness of varenicline as an aid to smoking cessation in primary care: an observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Comorbidity; Depression; Female; Germany; Humans; Hypertension; Incidence; Lung Diseases, Obstructive; Male; Middle Aged; Nicotinic Agonists; Observation; Primary Health Care; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence.
Topics: Adult; Benzazepines; Carbon Monoxide; Cross-Over Studies; Female; Humans; Male; Nicotinic Agonists; Prospective Studies; Quinoxalines; Reward; Sensitivity and Specificity; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Products; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2013 |
Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances.
Topics: Adolescent; Benzazepines; Bupropion; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Female; Genotype; Humans; Male; Nicotine; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Quinoxalines; Reproducibility of Results; Risk Factors; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
148 other study(ies) available for varenicline and Nicotine Addiction
| Article | Year |
|---|---|
Cost-effectiveness analysis of treatment with varenicline for nicotine dependence compared with smoking cessation without pharmacotherapy in the real world.
Topics: Adult; Bupropion; Cost-Benefit Analysis; Humans; Male; Retrospective Studies; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2022 |
Effectiveness of National Residential Smoking Cessation Program.
Topics: Humans; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2021 |
Assessing combined effects of varenicline and N-acetylcysteine on reducing nicotine seeking in rats.
Topics: Acetylcysteine; Animals; Nicotine; Rats; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2022 |
S3 Guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" - Short Version.
Topics: Adolescent; Alcoholism; Female; Humans; Pregnancy; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2022 |
Trapping of Nicotinic Acetylcholine Receptor Ligands Assayed by
Topics: Animals; Brain; Female; Ligands; Male; Mice; Nicotine; Positron-Emission Tomography; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline | 2023 |
Association of the Chantix Recall With US Prescribing of Varenicline and Other Medications for Nicotine Dependence.
Topics: Humans; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2023 |
Unavailability of varenicline: a global tragedy for the fight against the tobacco epidemic.
Topics: Humans; Nicotiana; Nicotinic Agonists; Tobacco Use Disorder; Varenicline | 2023 |
Using varenicline in combination with electronic nicotine delivery systems (ENDS).
Topics: Electronic Nicotine Delivery Systems; Humans; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; Varenicline | 2023 |
Habenular and striatal activity during performance feedback are differentially linked with state-like and trait-like aspects of tobacco use disorder.
Topics: Adolescent; Adult; Brain; Brain Mapping; Corpus Striatum; Feedback, Physiological; Female; Habenula; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Placebo Effect; Smokers; Task Performance and Analysis; Tobacco Use Disorder; Varenicline; Young Adult | 2019 |
Nicotine dependence (trait) and acute nicotinic stimulation (state) modulate attention but not inhibitory control: converging fMRI evidence from Go-Nogo and Flanker tasks.
Topics: Adolescent; Adult; Attention; Brain; Brain Mapping; Cross-Over Studies; Double-Blind Method; Executive Function; Female; Humans; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2020 |
Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Bupropion; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Retrospective Studies; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline; Young Adult | 2020 |
Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in Sprague-Dawley rats.
Topics: Alcohol Deterrents; Alcohol Drinking; Animals; Ethanol; Female; Male; Naltrexone; Nicotine; Rats; Rats, Sprague-Dawley; Self Administration; Smoking Cessation Agents; Tobacco Use Disorder; Varenicline | 2020 |
Investigating gender differences for effectiveness and side effects of varenicline during smoking cessation treatment.
Topics: Female; Humans; Male; Sex Factors; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2020 |
Increased striatal functional connectivity is associated with improved smoking cessation outcomes: A preliminary study.
Topics: Adult; Brain; Corpus Striatum; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Recurrence; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Varenicline | 2021 |
Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time.
Topics: Ambulatory Care Facilities; Cohort Studies; Czech Republic; Female; Humans; Male; Recurrence; Retrospective Studies; Smokers; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2021 |
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline.
Topics: Adult; Aged; Aged, 80 and over; Bupropion; Female; Humans; Male; Middle Aged; Practice Guidelines as Topic; Smoking Cessation Agents; Tobacco Use Disorder; United States; Varenicline | 2020 |
Essential tobacco dependence medicines in 137 countries.
Topics: Benzazepines; Bupropion; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2021 |
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Practice Guidelines as Topic; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2021 |
Treatment With Bupropion and Varenicline for Smoking Cessation and the Risk of Acute Cardiovascular Events and Injuries: a Swedish Case-Crossover Study.
Topics: Accidental Falls; Accidents, Traffic; Adult; Bupropion; Cardiovascular Diseases; Cross-Over Studies; Humans; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Suicide, Attempted; Sweden; Tobacco Use Disorder; Varenicline; Wounds and Injuries | 2018 |
Measures and predictors of varenicline adherence in the treatment of nicotine dependence.
Topics: Adult; Affect; Craving; Female; Humans; Logistic Models; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Saliva; Self Report; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2017 |
Modelling a budgetary impact analysis for funding drug-based smoking cessation therapies for patients with major depressive disorder in Spain.
Topics: Bupropion; Cost-Benefit Analysis; Depressive Disorder, Major; Female; Health Care Costs; Humans; Male; Markov Chains; Smoking; Smoking Cessation; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2017 |
ADHD symptoms impact smoking outcomes and withdrawal in response to Varenicline treatment for smoking cessation.
Topics: Attention Deficit Disorder with Hyperactivity; Conduct Disorder; Humans; Hyperkinesis; Impulsive Behavior; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2017 |
Psychotic Symptoms Associated With Varenicline in a Patient With Alcohol and Nicotine Dependence: A Case Report.
Topics: Adult; Alcoholism; Humans; Male; Nicotinic Agonists; Psychoses, Substance-Induced; Tobacco Use Disorder; Varenicline | 2017 |
Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
Topics: 5' Untranslated Regions; Adult; Aged; Bupropion; Carbon Monoxide; Exhalation; Female; Humans; Male; Middle Aged; Nerve Tissue Proteins; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2017 |
Could the nicotine receptor partial agonist varenicline moderate manic symptoms in heavy smokers with manic episodes?
Topics: Adult; Bipolar Disorder; Humans; Male; Nicotinic Agonists; Smoking; Tobacco Use Disorder; Varenicline | 2018 |
Improvement of the association between self-reported pill count and varenicline levels following exclusion of participants with misreported pill count: A commentary on Peng et al. (2017).
Topics: Adult; Area Under Curve; Female; Humans; Male; Medication Adherence; Middle Aged; ROC Curve; Saliva; Self Report; Smoking Cessation Agents; Tobacco Use Disorder; Varenicline | 2018 |
Comparative Effectiveness of Varenicline and Nicotine Replacement Therapy for Smoking Cessation in Older and Younger Smokers: A Prospective Cohort in Taiwan.
Topics: Adult; Age Factors; Aged; Cohort Studies; Female; Humans; Male; Middle Aged; Prospective Studies; Smoking; Smoking Cessation; Smoking Cessation Agents; Taiwan; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2019 |
Preclinical evidence for combining the 5-HT
Topics: Animals; Benzazepines; Conditioning, Operant; Drug Combinations; Drug-Seeking Behavior; Feeding Behavior; Impulsive Behavior; Male; Rats, Long-Evans; Reinforcement, Psychology; Serotonin 5-HT2 Receptor Agonists; Smoking Cessation Agents; Tobacco Use Disorder; Varenicline | 2019 |
New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.
Topics: Animals; Dose-Response Relationship, Drug; Female; Hyperalgesia; Male; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Transgenic; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Reward; Smoking Cessation Agents; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2018 |
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment.
Topics: Adolescent; Adult; Aged; alpha7 Nicotinic Acetylcholine Receptor; DNA Copy Number Variations; Drug Resistance; Female; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Smoking Cessation Agents; Tobacco Use Disorder; Varenicline | 2018 |
Rapid nicotine tolerance and cross-tolerance to varenicline in rhesus monkeys: Drug discrimination.
Topics: Animals; Discrimination Learning; Dose-Response Relationship, Drug; Drug Tolerance; Female; Macaca mulatta; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2018 |
Real-World Effectiveness of Pharmaceutical Smoking Cessation Aids: Time-Varying Effects.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Female; Health Behavior; Humans; Male; Middle Aged; Nicotinic Agonists; Ontario; Pharmaceutic Aids; Smokers; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2020 |
An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDI.
Topics: Alcohol Deterrents; Alcohol Drinking; Animals; Disease Models, Animal; Ethanol; Female; Naltrexone; Nicotine; Nicotinic Antagonists; Picolines; Pyridinium Compounds; Rats; Self Administration; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2018 |
Varenicline for long term smoking cessation in patients with COPD.
Topics: Adult; Airway Obstruction; Carbon Monoxide; Cohort Studies; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2018 |
Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats.
Topics: Alcohol Deterrents; Alcohol Drinking; Animals; Ethanol; Female; Injections, Subcutaneous; Naltrexone; Nicotine; Random Allocation; Rats; Self Administration; Smoking Cessation Agents; Tobacco Use Disorder; Varenicline | 2019 |
Moderators of real-world effectiveness of smoking cessation aids: a population study.
Topics: Adolescent; Adult; Age Factors; Aged; Bupropion; Counseling; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; England; Female; Humans; Hypnosis; Internet; Male; Middle Aged; Nonprescription Drugs; Sex Factors; Smoking Cessation; Smoking Cessation Agents; Social Class; Surveys and Questionnaires; Telephone; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2019 |
The association between cognitive coping strategies and treatment outcomes in smokers with PTSD.
Topics: Adaptation, Psychological; Adult; Chronic Disease; Combined Modality Therapy; Comorbidity; Counseling; Female; Follow-Up Studies; Humans; Implosive Therapy; Male; Middle Aged; Smokers; Smoking Cessation; Smoking Cessation Agents; Stress Disorders, Post-Traumatic; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2020 |
Assessing nicotine dependence using an oral nicotine free-choice paradigm in mice.
Topics: Animals; Behavior, Addictive; Choice Behavior; Dose-Response Relationship, Drug; Drug Interactions; Female; Male; Mice; Mice, Knockout; Nicotine; Nucleus Accumbens; Quinine; Receptors, Nicotinic; Self Administration; Sex Characteristics; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tyrosine 3-Monooxygenase; Varenicline | 2019 |
Predictors of long-term abstinence rate by income level in the Korean smoking cessation programme.
Topics: Adult; Bupropion; Female; Humans; Income; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Republic of Korea; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2019 |
Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders.
Topics: Drug Prescriptions; Female; Humans; Male; Mental Disorders; Mental Health; Middle Aged; Nicotine; Nicotinic Agonists; Prospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2020 |
Adherence to varenicline and associated smoking cessation in a community-based patient setting.
Topics: Adult; Benzazepines; Cohort Studies; Community Health Centers; Electronic Health Records; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Pennsylvania; Primary Health Care; Provider-Sponsored Organizations; Quinoxalines; Retrospective Studies; Self Report; Smoking Cessation; Tobacco Use Disorder; Treatment Refusal; Varenicline | 2013 |
Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.
Topics: Adult; Aged; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Prescriptions; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Risk Assessment; Risk Factors; Sentinel Surveillance; Smoking Cessation; Tobacco Use Disorder; United States; United States Food and Drug Administration; Varenicline | 2013 |
Treatment of smoking in smokers with chronic obstructive pulmonary disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Motivation; Multicenter Studies as Topic; Program Evaluation; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Reward; Severity of Illness Index; Smoking; Smoking Cessation; Spain; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.
Topics: Adult; Benzazepines; Bupropion; Clinical Trials as Topic; Computer Simulation; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Economic; Quality of Life; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews.
Topics: Alkaloids; Azocines; Behavior Therapy; Behavior, Addictive; Benzazepines; Humans; Meta-Analysis as Topic; Nicotinic Agonists; Quinolizines; Quinoxalines; Review Literature as Topic; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.
Topics: Alkaloids; Animals; Azocines; Behavior, Animal; Benzazepines; Brain; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Drug Partial Agonism; HEK293 Cells; Humans; Male; Membrane Potentials; Mice; Molecular Structure; Nicotinic Agonists; Oocytes; Patch-Clamp Techniques; Quinolizines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline; Xenopus laevis | 2013 |
Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.
Topics: Animals; Benzazepines; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Feeding Behavior; Female; Macaca mulatta; Male; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Reinforcement, Psychology; Self Administration; Tobacco Use Disorder; Varenicline | 2014 |
Functional interactions of varenicline and nicotine with nAChR subtypes implicated in cardiovascular control.
Topics: Animals; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Oocytes; Protein Binding; Quinoxalines; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline; Xenopus laevis | 2014 |
Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Azetidines; Benzazepines; Brain Chemistry; Drug Evaluation, Preclinical; Feeding Behavior; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Up-Regulation; Varenicline; Weight Gain | 2014 |
[Safety of nicotine addiction treatment].
Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Quinolizines; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Tobacco Use Disorder; Varenicline; Xerostomia | 2013 |
Placebo controlled trials.
Topics: Benzazepines; Confounding Factors, Epidemiologic; Humans; Nicotinic Agonists; Placebos; Quinoxalines; Randomized Controlled Trials as Topic; Research Design; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2014 |
Tobacco quitline outcomes by service type.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cohort Studies; Combined Modality Therapy; Counseling; Dopamine Uptake Inhibitors; Female; Hotlines; Humans; Longitudinal Studies; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; South Dakota; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2014 |
Larval zebrafish model for FDA-approved drug repositioning for tobacco dependence treatment.
Topics: Animals; Benzazepines; Drug Repositioning; Models, Animal; Nicotine; Quinoxalines; Tobacco Use Disorder; United States; United States Food and Drug Administration; Varenicline; Zebrafish | 2014 |
Predictors of lapse and relapse to smoking in successful quitters in a varenicline post hoc analysis in Japanese smokers.
Topics: Adult; Aged; Asian People; Chronic Disease; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
Association of out-of-pocket pharmacy costs with adherence to varenicline.
Topics: Aged; Benzazepines; Community Pharmacy Services; Drug Costs; Female; Health Expenditures; Humans; Linear Models; Logistic Models; Male; Medicare; Medication Adherence; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Retrospective Studies; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; Varenicline | 2014 |
[Vareniklin: a safe treatment of tobacco dependency for cardiovascular patients].
Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2014 |
The role of impulsivity in dropout from treatment for cigarette smoking.
Topics: Adult; Benzazepines; Case-Control Studies; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Delay Discounting; Female; Humans; Impulsive Behavior; Male; Middle Aged; Patient Dropouts; Personality; Personality Inventory; Quinoxalines; Recurrence; Smoking; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
Use of varenicline for smoking cessation treatment in UK primary care: an association rule mining analysis.
Topics: Adolescent; Adult; Age Distribution; Benzazepines; Databases, Factual; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Primary Health Care; Quinoxalines; Sexism; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; United Kingdom; Varenicline; Young Adult | 2014 |
Repeating the same mistake.
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2014 |
Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects!
Topics: Benzazepines; Drug Administration Schedule; Humans; Nicotinic Agonists; Quinoxalines; Recurrence; Retreatment; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Providing medication therapy management for smoking cessation patients.
Topics: Bupropion; Humans; Medication Adherence; Medication Therapy Management; Nicotinic Agonists; Professional Role; Risk Factors; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline | 2015 |
[Effectiveness of Varenicline with counseling programs on smoking cessation in a targeted clinical setting in China].
Topics: Benzazepines; China; Counseling; Female; Humans; Male; Nicotinic Agonists; Prospective Studies; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2014 |
Adherence to Tobacco Dependence Treatment Among HIV-Infected Smokers.
Topics: Adult; Counseling; Female; HIV Infections; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking Cessation; Telemedicine; Telephone; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2016 |
Extended varenicline treatment in a severe cardiopathic cigarette smoker: a case report.
Topics: Bupropion; Counseling; Heart Diseases; Humans; Male; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2015 |
Noribogaine reduces nicotine self-administration in rats.
Topics: Animals; Dose-Response Relationship, Drug; Ibogaine; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2015 |
Formative Evaluation of a Text Messaging Intervention to Promote Varenicline Adherence Among Tobacco-Dependent Persons with HIV.
Topics: Adult; Benzazepines; Feasibility Studies; Female; Focus Groups; HIV Infections; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Program Evaluation; Quinoxalines; Smoking Cessation; Text Messaging; Tobacco Use Disorder; Varenicline | 2015 |
Medicaid, Private Insurance, and the Availability of Smoking Cessation Interventions in Substance Use Disorder Treatment.
Topics: Bupropion; Counseling; Humans; Insurance Carriers; Insurance Coverage; Logistic Models; Medicaid; Multivariate Analysis; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline | 2015 |
Quitting smoking before and after varenicline: a population study based on two representative samples of US smokers.
Topics: Adolescent; Adult; Aged; Bupropion; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Recurrence; Smokers; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline; Young Adult | 2016 |
Smoking cessation and the effect of nicotine dependence on relapse rate in Izmir, Turkey.
Topics: Adult; Behavior Therapy; Benzazepines; Bupropion; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Turkey; Varenicline | 2015 |
Vascular Functional and Morphological Alterations in Smokers during Varenicline Therapy.
Topics: Adult; Aged; Benzazepines; Brachial Artery; Case-Control Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Nitroglycerin; Quinoxalines; Recovery of Function; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome; Ultrasonography; Varenicline; Vasodilation; Vasodilator Agents; Young Adult | 2015 |
Extended nicotine self-administration increases sensitivity to nicotine, motivation to seek nicotine and the reinforcing properties of nicotine-paired cues.
Topics: Animals; Behavior, Animal; Cues; Drug-Seeking Behavior; Male; Motivation; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Tobacco Use Disorder; Varenicline | 2017 |
Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD.
Topics: Adult; Aged; Aged, 80 and over; Bupropion; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Admission; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; United States Department of Veterans Affairs; Varenicline | 2016 |
Nicotine lozenges and behavioural interventions may help smokeless tobacco users to quit.
Topics: Behavior Therapy; Chewing Gum; Evidence-Based Dentistry; Humans; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2015 |
Factors affecting dropout in the smoking cessation outpatient clinic.
Topics: Adult; Age Factors; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Educational Status; Female; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Patient Dropouts; Retrospective Studies; Sex Factors; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2016 |
Drugs for smoking cessation.
Topics: Bupropion; Contraindications; Dopamine Uptake Inhibitors; Drug Monitoring; Female; Humans; Middle Aged; Nicotinic Agonists; Practice Guidelines as Topic; Pregnancy; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Varenicline impairs extinction and enhances reinstatement across repeated cycles of nicotine self-administration in rats.
Topics: Animals; Catheters, Indwelling; Disease Models, Animal; Drug-Seeking Behavior; Extinction, Psychological; Male; Motor Activity; Nicotine; Nicotinic Agonists; Rats, Sprague-Dawley; Self Administration; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Commentary on Roberts et al. (2016): Bupropion and varenicline are efficacious and well-tolerated cessation medications for smokers with serious mental illness.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2016 |
Comparative Effectiveness of Smoking Cessation Medications to Attenuate Weight Gain Following Cessation.
Topics: Adult; Bupropion; Female; Humans; Male; Middle Aged; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Weight Gain | 2016 |
The use of varenicline to treat nicotine dependence among patients with cancer.
Topics: Adult; Benzazepines; Bupropion; Counseling; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2017 |
Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo-controlled studies of varenicline.
Topics: Adolescent; Adult; Aged; Diabetes Complications; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Randomized Controlled Trials as Topic; Retrospective Studies; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2017 |
Varenicline, the clinically effective smoking cessation agent, restores probabilistic response reversal performance during withdrawal from nicotine.
Topics: Animals; Male; Nicotine; Nicotinic Agonists; Probability Learning; Psychomotor Performance; Rats; Reaction Time; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2017 |
Gender difference and effect of pharmacotherapy: findings from a smoking cessation service.
Topics: Adolescent; Adult; Aged; Benzazepines; Counseling; England; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Sex Factors; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2016 |
Increased network centrality as markers of relapse risk in nicotine-dependent individuals treated with varenicline.
Topics: Adult; Brain; Brain Mapping; Echo-Planar Imaging; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Nicotinic Agonists; Oxygen; Recurrence; Tobacco Use Disorder; Varenicline | 2017 |
Default mode network deactivation to smoking cue relative to food cue predicts treatment outcome in nicotine use disorder.
Topics: Adolescent; Adult; Brain; Cigarette Smoking; Cues; Female; Food; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2018 |
Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy.
Topics: Attention; Bipolar Disorder; Cognitive Behavioral Therapy; Comorbidity; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Outpatients; Schizophrenia; Smokers; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2017 |
Varenicline reduced smoking behaviour in a mentally ill person.
Topics: Benzazepines; Bipolar Disorder; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Varenicline (Chantix) warnings: risk versus benefit.
Topics: Benzazepines; Drug Partial Agonism; Humans; Mental Disorders; Nicotinic Agonists; Quinoxalines; Risk Assessment; Risk Factors; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression.
Topics: Adult; Alcoholism; Benzazepines; Depressive Disorder, Major; Humans; Male; Mental Disorders; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.
Topics: Animals; Behavior, Animal; Benzazepines; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Fear; Freezing Reaction, Cataleptic; Learning Disabilities; Male; Mice; Mice, Inbred C57BL; Nicotinic Agonists; Quinoxalines; Tobacco Use Disorder; Varenicline | 2008 |
Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission.
Topics: Adult; Amphetamine-Related Disorders; Benzazepines; Borderline Personality Disorder; Depressive Disorder, Major; Drug Partial Agonism; Female; Humans; Irritable Mood; Methamphetamine; Nicotinic Agonists; Paranoid Disorders; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2008 |
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Brain; Bupropion; Dopamine; Dose-Response Relationship, Drug; Drugs, Investigational; Male; Neurons; Nicotine; Nicotinic Antagonists; Picolines; Quaternary Ammonium Compounds; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Nicotinic; Reward; Smoking Cessation; Structure-Activity Relationship; Tobacco Use Disorder; Varenicline; Ventral Tegmental Area | 2009 |
A 51-year-old woman with bipolar disorder who wants to quit smoking.
Topics: Benzazepines; Bipolar Disorder; Bupropion; Counseling; Female; Humans; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2009 |
[Specific program for smoking cessation: thus your patients become nonsmokers].
Topics: Behavior Therapy; Benzazepines; Bupropion; Carbon Monoxide; Contraindications; Humans; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Varenicline for tobacco dependence.
Topics: Affect; Behavior; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Suicide; Tobacco Use Disorder; Varenicline | 2009 |
Varenicline for tobacco dependence.
Topics: Benzazepines; Humans; Mental Disorders; Nicotinic Agonists; Quinoxalines; Smoking; Suicide; Tobacco Use Disorder; Varenicline | 2009 |
[Varenicline - pharmacological therapy of tobacco dependence].
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Clinical Trials as Topic; Contraindications; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Pregnancy; Prospective Studies; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline | 2009 |
A reader responds to "Seven pharmacotherapies do promote smoking abstinence at 6 and 12 months".
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Varenicline augmentation in depressed smokers: an 8-week, open-label study.
Topics: Adolescent; Adult; Aged; Benzazepines; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Psychotropic Drugs; Quinoxalines; Receptors, Nicotinic; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Benzazepines; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Sex Factors; Smoking Cessation; Tobacco Use Disorder; Varenicline; Veterans | 2009 |
Reduced affective symptoms during tobacco dependence treatment with varenicline.
Topics: Affective Symptoms; Benzazepines; Depressive Disorder; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.
Topics: Affect; Alcohol Drinking; Animals; Attention; Benzazepines; Cerebral Cortex; Cognition; Depression; Drug Partial Agonism; Hippocampus; Humans; Male; Mice; Mice, Inbred C57BL; Neurotransmitter Agents; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Nicotinic; Recognition, Psychology; Reflex, Startle; Reward; Tobacco Use Disorder; Varenicline | 2009 |
[Current and future medical drugs for smoking cessation].
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
Safety of smoking cessation drugs.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
[Drug treatment of tobacco dependence].
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Meta-Analysis as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.
Topics: Animals; Association Learning; Behavior, Animal; Benzazepines; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Exploratory Behavior; Food; Male; Models, Animal; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Receptors, Nicotinic; Recurrence; Reinforcement, Psychology; Self Administration; Tobacco Use Disorder; Varenicline | 2010 |
Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Costs and Cost Analysis; Databases, Factual; Dopamine Uptake Inhibitors; Female; Finland; Humans; Male; Markov Chains; Middle Aged; Models, Theoretical; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Integrating smoking cessation into HIV care.
Topics: Anti-HIV Agents; Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Government Programs; HIV Infections; Humans; Nicotinic Agonists; Oregon; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2010 |
Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats.
Topics: Animals; Benzazepines; Conditioning, Classical; Dose-Response Relationship, Drug; Male; Mecamylamine; Morphine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Tobacco Use Disorder; Varenicline | 2010 |
Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.
Topics: Alkaloids; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Azepines; Azocines; Benzazepines; Brain; Dopamine; Heterocyclic Compounds, 4 or More Rings; Humans; Limbic System; Male; Mice; Mice, Knockout; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Smoking Cessation; Tissue Distribution; Tobacco Use Disorder; Varenicline; Xenopus laevis | 2010 |
Varenicline does not increase serum BDNF levels in patients with nicotine dependence.
Topics: Adult; Aged; Benzazepines; Brain-Derived Neurotrophic Factor; Female; Humans; Male; Middle Aged; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
Topics: Adolescent; Adult; Benzazepines; Counseling; Female; Humans; Male; Montana; Nicotine; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Telephone; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2010 |
Current treatment options in smoking cessation.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Patient Selection; Piperidines; Practice Guidelines as Topic; Pyrazoles; Quinoxalines; Rimonabant; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; United States; Vaccines; Varenicline | 2010 |
[The management of patients with nicotine dependence - the role of the general practitioners].
Topics: Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Disease Management; Dopamine Uptake Inhibitors; Family Practice; Humans; Motivation; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Switzerland; Tobacco Use Disorder; Varenicline | 2010 |
[Medical therapy for smoking cessation].
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Antidepressive Agents; Benzazepines; Bupropion; Chewing Gum; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Nicotine gum dependence treated with varenicline--a case report.
Topics: Adult; Benzazepines; Female; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2010 |
Mental health stability in veterans with posttraumatic stress disorder receiving varenicline.
Topics: Benzazepines; Female; Hospitals, Veterans; Humans; Male; Mental Health Services; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Stress Disorders, Post-Traumatic; Tobacco Use Disorder; Varenicline; Veterans | 2010 |
Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats.
Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Male; Nicotinic Agonists; Quinoxalines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Time Factors; Tobacco Use Disorder; Varenicline | 2011 |
Drug treatment for users of smokeless tobacco.
Topics: Benzazepines; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2010 |
Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.
Topics: Adolescent; Adult; Aged; Australia; Benzazepines; Bupropion; Canada; Cohort Studies; Data Collection; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nonprescription Drugs; Prescription Drugs; Prevalence; Quinoxalines; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome; United Kingdom; United States; Varenicline; Young Adult | 2011 |
Integrating results from smoking cessation drug research and development into clinical occupational health practice.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Occupational Health Nursing; Practice Guidelines as Topic; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.
Topics: Adult; Benzazepines; Clinical Trials as Topic; Female; Health Care Costs; Humans; Male; Models, Statistical; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
Varenicline and the evaluation of neuropsychiatric adverse events in smokers.
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
Breaking free from nicotine dependence. A combination of strategies boosts the odds of success.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
Treatment of nicotine dependence with Chantix (varenicline).
Topics: Adult; Benzazepines; Disclosure; Drug Interactions; Humans; Mental Disorders; Nausea; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Randomized Controlled Trials as Topic; Risk Assessment; Safety; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2011 |
Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used.
Topics: Animals; Benzazepines; Conditioning, Operant; Cues; Data Interpretation, Statistical; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Feeding Behavior; Male; Motivation; Nicotine; Quinoxalines; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Reinforcement Schedule; Self Administration; Tobacco Use Disorder; Varenicline | 2012 |
[Smoking cessation--assistance for the general practitioner].
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Complementary Therapies; Cost-Benefit Analysis; Drug Costs; Fee Schedules; Germany; Humans; Myocardial Infarction; National Health Programs; Nicotine; Nicotinic Agonists; Physician's Role; Polymethacrylic Acids; Polyvinyls; Psychotherapy, Group; Quinoxalines; Smoking Cessation; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2011 |
Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine.
Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2012 |
Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline.
Topics: Adult; Benzazepines; Catecholamines; Depression; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2012 |
Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-11.
Topics: Adult; Benzazepines; Bupropion; Counseling; Cross-Sectional Studies; Dopamine Uptake Inhibitors; England; Female; Health Behavior; Humans; Longitudinal Studies; Male; Motivation; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
Topics: Adult; Aged; Benzazepines; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2012 |
Adherence to varenicline among African American smokers: an exploratory analysis comparing plasma concentration, pill count, and self-report.
Topics: Adult; Attitude to Health; Benzazepines; Biomarkers; Black or African American; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Self Report; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2012 |
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Topics: Benzazepines; Bupropion; Computer Simulation; Cost Savings; Cost-Benefit Analysis; Drug Costs; Greece; Health Care Costs; Humans; Insurance, Health, Reimbursement; Markov Chains; Models, Economic; Monte Carlo Method; Prevalence; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
Adverse neuropsychiatric events associated with varenicline use in veterans: a case series.
Topics: Adult; Benzazepines; Bipolar Disorder; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Stress Disorders, Post-Traumatic; Suicidal Ideation; Tobacco Use Disorder; United States; Varenicline; Veterans | 2012 |
Strategies to help a smoker who is struggling to quit.
Topics: Behavior Therapy; Benzazepines; Bupropion; Chronic Disease; Counseling; Disease Management; Dopamine Uptake Inhibitors; Hotlines; Humans; Male; Middle Aged; Nicotinic Agonists; Physician-Patient Relations; Physician's Role; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2012 |
[Methods and results of smoking cessation in cancer smoker's].
Topics: Benzazepines; Bupropion; Humans; Neoplasms; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Smoke Pollution; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2012 |
[Consensus report for the clinical care of smoking cessation in Spain. Comité Nacional para la Prevención del Tabaquismo].
Topics: Benzazepines; Bupropion; Counseling; Humans; Motivation; Nicotinic Agonists; Patient Compliance; Patient Education as Topic; Persuasive Communication; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale.
Topics: Adolescent; Adult; Aged; Benzazepines; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Minnesota; Nicotinic Agonists; Psychometrics; Quinoxalines; Reproducibility of Results; Severity of Illness Index; Sickness Impact Profile; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Varenicline | 2005 |
[Medication for ending tobacco dependency. Current state].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Humans; Nicotine; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Smoking Cessation; Time Factors; Tobacco Use Disorder; Varenicline | 2005 |
The neurobiological basis for partial agonist treatment of nicotine dependence.
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2006 |
Varenicline.
Topics: Benzazepines; Clinical Trials as Topic; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2006 |
Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Appetitive Behavior; Azetidines; Benzazepines; Corpus Striatum; Cystine; Discrimination Learning; Dose-Response Relationship, Drug; Male; Motivation; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline | 2007 |
[Tobacco use prevention and cessation in the dental practice].
Topics: Behavior Therapy; Benzazepines; Bupropion; Dentist-Patient Relations; Health Plan Implementation; Humans; Interview, Psychological; Mouth Neoplasms; Nicotinic Agonists; Obesity; Periodontitis; Professional Role; Quinoxalines; Self Efficacy; Surveys and Questionnaires; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline; Weight Gain | 2007 |
A call to action: new treatment options provide even more reasons to intervene in tobacco dependence.
Topics: Benzazepines; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Obesity; Piperidines; Prevalence; Pyrazoles; Quinoxalines; Rimonabant; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
A new medication for the worst addiction.
Topics: Benzazepines; Bupropion; Drug Administration Schedule; Follow-Up Studies; Humans; Multicenter Studies as Topic; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2007 |
A second varenicline trial.
Topics: Benzazepines; Bupropion; Delayed-Action Preparations; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2007 |
Varenicline as maintenance therapy.
Topics: Benzazepines; Double-Blind Method; Follow-Up Studies; Humans; Long-Term Care; Multicenter Studies as Topic; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Topics: Adult; Benzazepines; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Humans; London; Male; Mental Disorders; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Stat bite: Medicaid coverage of tobacco-dependence treatments.
Topics: Administration, Cutaneous; Administration, Intranasal; Administration, Oral; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Insurance Coverage; Male; Medicaid; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Tobacco Use Disorder; United States; Varenicline | 2008 |